Plain-English translation of NCT06501599 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are testing a new artificial intelligence system designed to analyze chest CT scan images and automatically detect patterns of lung damage caused by viral pneumonia, including COVID-19. The AI system aims to highlight areas of damage and provide doctors with detailed measurements of how much of the lung is affected. This study will check whether the AI system works as well as the company claims it should.
Doctors need faster, more consistent ways to identify and measure lung damage from viral pneumonia on CT scans. This study will validate whether the new treatment can help radiologists and doctors make more accurate diagnoses and track disease severity.
This is a retrospective study, meaning researchers will review your existing chest CT scans that you've already had — you won't need to come in for new scans. Your de-identified scan images (with your personal information removed) will be included in a dataset used to test and validate the AI system's ability to detect and measure viral pneumonia-related lung damage. The study involves no procedures, medications, or additional visits on your part.
AI-generated summary from trial data · Jun 20, 2026 · Not medical advice
Russia